J.A. Moreno-Monteagudo

Author

Hospital Universitario de La Princesa ORCID

Also Known As

J A Moreno-Monteagudo, J. A. MORENO‐MONTEAGUDO, J. A. Moreno-Monteagudo, J. A. Moreno‐Monteagudo, J.A. Moreno-Monteagudo, José A Moreno-Monteagudo, José A. Moreno-Monteagudo, José Andrés Moreno-Monteagudo, José Andrés Moreno‐Monteagudo

Publications

513

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario de La Princesa Universidad Autónoma de Madrid Instituto de Biomedicina y Genética Molecular de Valladolid Universidad de Valladolid Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

About

J.A. Moreno-Monteagudo is an author at Hospital Universitario de La Princesa specializing in immunology, hepatitis, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	18
2	Hepatology	1	1	18
3	Immunology	1	1	18
4	Viral Hepatitis	1	1	18
5	Clinical Hepatology	1	1	18

J.A. Moreno-Monteagudo

Publications

490

Citations

H-Index

Page 1

	Year	Citations
A pilot study of atorvastatin treatment in dyslipemid, non‐alcoholic fatty liver patients Elena Gómez Domínguez, Javier P. Gisbert, J.A. Moreno-Monteagudo, Alimentary Pharmacology & Therapeutics	2006	188
Transient elastography: a valid alternative to biopsy in patients with chronic liver disease Elena Gómez Domínguez, Jorge Mendoza, J.A. Moreno-Monteagudo, Alimentary Pharmacology & Therapeutics	2006	109
Chronic Hepatitis C in Children: A Clinical and Immunohistochemical Comparative Study With Adult Patients Carmelo García‐Monzón, Paloma Jara, Miguel Fernández‐Bermejo, Hepatology	1998	80
Immunomodulatory Effect of Gut Microbiota-Derived Bioactive Peptides on Human Immune System from Healthy Controls and Patients with Inflammatory Bowel Disease Samuel Fernández‐Tomé, Alicia C Marín, Lorena Ortega Moreno, Nutrients	2019	41
Lunasin Peptide is a Modulator of the Immune Response in the Human Gastrointestinal Tract Samuel Fernández‐Tomé, Pedro Indiano‐Romacho, Irene Mora‐Gutiérrez, Molecular Nutrition & Food Research	2021	24
Clinical and Pathological Characteristics and Response to Combination Therapy of Genotype 4 Chronic Hepatitis C Patients: Experience from a Spanish Center María Trapero-Marugán, J.A. Moreno-Monteagudo, Luisa Garcı́a-Buey, Journal of Chemotherapy	2007	20
Response To Retreatment With Interferon-α Plus Ribavirin in Chronic Hepatitis C Patients Is Independent of The Ns5a Gene Nucleotide Sequence Nieves Ibarrola, J.A. Moreno-Monteagudo, Margarita Sáiz, The American Journal of Gastroenterology Ns5a GeneHepatic DisordersHepatologyHepatitis CViral Hepatitis	1999	18
Interferon‐α plus ribavirin for 12 months increases the sustained response rates in chronic hepatitis C relapsers J.A. Moreno-Monteagudo, Á. Castro, A. de Pedro, Alimentary Pharmacology & Therapeutics	2002	10

Page 1